You are here

Article Text

Article menu
Download PDFPDF
Cervical Cancer
Outcomes of Cervical Cancer and Positive Para-aortic Lymph Nodes in the Modern Era of Chemoradiation
  1. LaToya J. Perry, MD*,
  2. Cara Mathews, MD†,
  3. Elizabeth Nugent, MD*,
  4. Regina Farrell, MD*,
  5. Kristen Zorn, MD‡ and
  6. Kathleen Moore, MD*
  1. *Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK;
  2. †Women and Infant’s Hospital, Brown University, Providence, RI; and
  3. ‡Magee-Women’s Hospital of UPMC, Pittsburgh, PA.
  1. Address correspondence and reprint requests to Kathleen N. Moore, MD, Stephenson Oklahoma Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK. E-mail: Kathleen-moore{at}ouhsc.edu.

Abstract

Objective Patients with cervical cancer with positive para-aortic lymph nodes have a poor prognosis. Our primary aim was to describe outcomes among this subgroup in the era of modern chemoradiation.

Methods Patients with histologically confirmed cervical cancer metastatic to their para-aortic lymph nodes diagnosed between 1998 and 2011 and treated with curative intent were included in this analysis. Surgicopathologic, demographic, and outcome data were collected. Descriptive and survival statistics were generated to evaluate overall survival (OS) and progression-free survival (PFS) and to compare outcomes by treatment. P values were generated using both Wilcoxon and log-rank methods and listed respectively.

Results The median PFS was 19 months. The median OS was 23.4 months. The median PFS for radiation only was 14 months and for chemoradiation was 20 months (P = 0.27 and 0.60, respectively). There was no difference in median OS for the radiation-only group versus chemoradiation. The median OS stratified by stage was 32 months (stage I), 21 months (stage II), 19.4 months (stage III), and 19.8 months (stage IV; P = 0.17 and 0.22).

Conclusions Our study shows a median OS of 23 months, which is less than what was documented in the literature. Despite the use of modern chemoradiation therapy, most of the cohort died within 3 years. The low OS presented in our study highlights the limitations of the current treatment regimens and the need for identification of for more effective therapy.

  • Cervical cancer
  • Positive para-aortic lymph nodes
  • Overall survival

https://doi.org/10.1097/IGC.0000000000000093

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • The authors declare no conflicts of interest.